Results Group, LLC

Results Group, LLC, headquartered in Glastonbury, Connecticut, is a small disadvantaged business specializing in advanced assistive technologies and rehabilitation devices with a primary focus on exoskeleton-integrated systems. The company, organized as a limited liability company, has established itself as a provider of innovative medical technologies designed to address complex mobility enhancement and injury recovery challenges for both military personnel and civilian populations. Results Group leverages expertise in developing cutting-edge exoskeleton technologies that serve diverse rehabilitation needs, from military return-to-duty applications to civilian medical conditions.

Results Group has demonstrated significant federal contracting activity through the Small Business Innovation Research (SBIR) Program, receiving three substantial Phase II contracts totaling approximately $1.9 million from defense-focused agencies. The company was awarded a $1,099,999.24 firm fixed-price Phase II contract by the Department of Defense Medical Command in August 2022 for the development of a "Multi-Mode Exoskeleton Boot to Facilitate Rehabilitation and Return to Service," with a completion date of December 21, 2024. Subsequently, Results Group received a $549,965.00 Phase II Enhancement contract from the Defense Health Agency with an ultimate completion date of November 13, 2026, supporting the same exoskeleton boot development initiative under the total small business set-aside designation. Most recently, in August 2025, the company secured a $249,992.67 Phase I SBIR contract from the U.S. Department of the Army, also structured as a firm fixed-price definitive contract with total small business set-aside designation and scheduled for completion by February 24, 2026. All contracts reflect the company's focus on developing rehabilitation devices that support mobility enhancement and injury recovery within a defense and military health context.

Results Group has secured four substantial federal grant awards totaling approximately $3.3 million, demonstrating a diversified portfolio of research and development initiatives across military and civilian medical applications. The Defense Health Agency awarded a $1,499,872 Project Grant under the Military Medical Research and Development program (CFDA 12.420) with a performance period from September 1, 2024 to August 31, 2026, focusing on deploying exoskeleton-integrated boots to support longer-term rehabilitation protocols for military personnel recovering from lateral ankle sprains. The National Institute of Nursing Research funded a $100,000+ Project Grant (awarded May 17, 2021, with completion in April 2025) for development of assistive exoskeleton and exotendon systems to address diabetic foot ulcer complications, demonstrating the company's work in civilian health applications. The National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) has been a recurring partner, awarding two grants totaling $300,000. The first, awarded June 1, 2024 and completed November 30, 2024, supported user-centric development of exoskeletons as alternatives to traditional ankle-foot orthoses for adolescents with Charcot-Marie-Tooth disease. The second grant, awarded June 1, 2025 with completion targeted for January 15, 2026, is a $200,000 six-month project grant conducted in partnership with the Charcot-Marie-Tooth Association and CMT Centers of Excellence at Mass General Hospital, St. Jude Hospital, and Children's Hospital of Colorado to design and test exoskeleton-integrated boot systems for youth with CMT disease. These grant initiatives collectively demonstrate Results Group's commitment to advancing rehabilitative technologies across military medical research, civilian health conditions, and disability services.

We specialize in new product innovation and development services in the fields of healthcare, manufacturing and consumer products.